Yellowish Eyes In Newborns: A Common Concern For Parents

It is not uncommon for newborn babies to have yellowish eyes. This condition, known as jaundice, affects about 60% of full-term babies and is even more prevalent in premature infants, with rates of around 80%. Jaundice is characterised by a yellow discolouration of the skin and eyes, typically appearing within the first few days after birth. It is caused by an excess of bilirubin in the blood, which is produced during the normal breakdown of red blood cells. While most cases of jaundice are mild and resolve on their own within a couple of weeks, it is important to monitor newborns for any signs of severe jaundice, as high levels of bilirubin can lead to serious complications such as brain damage.

Jaundice is caused by a build-up of bilirubin in the blood

It is not uncommon for newborn babies to have yellowish eyes. This condition, known as jaundice, is caused by a build-up of bilirubin in the blood. Bilirubin is a yellow substance that is produced when red blood cells break down. While this is a normal part of the cell cycle, newborns have more red blood cells than adults, and their livers are not yet mature enough to process the bilirubin efficiently. This can lead to a build-up of bilirubin in the blood, causing the skin and eyes to appear yellow.

In most cases, jaundice in newborns is a mild condition that resolves within 2 to 3 weeks as the baby's liver matures and they start feeding. It is often referred to as physiological jaundice and accounts for about 75% of cases. To help lower bilirubin levels in breastfed babies, it is recommended to initiate breastfeeding as soon as possible after birth, preferably within the first hour. Frequent and unrestricted breastfeeding can help eliminate bilirubin from the baby's body.

However, in some cases, jaundice can be an indication of an underlying medical condition. This is known as pathological jaundice and may be caused by factors such as blood type incompatibilities, breakdown of red blood cells, breastfeeding difficulties, or certain medications. If jaundice persists or is accompanied by other symptoms such as increased sleepiness, poor feeding, or a high-pitched cry, it is important to seek medical advice.

Left untreated, severe jaundice in newborns can lead to acute bilirubin encephalopathy, which is caused by toxic levels of bilirubin in the brain. This can progress to kernicterus, resulting in permanent brain damage. Therefore, close monitoring of bilirubin levels and early intervention are crucial to prevent complications.

Bilirubin is a yellow substance produced by the breakdown of red blood cells

It is normal for newborn babies to have yellowish eyes, and this condition is called jaundice. It is caused by a build-up of bilirubin in the body. Bilirubin is a yellow substance produced by the breakdown of red blood cells. The liver usually processes and removes bilirubin from the blood, but newborn babies' livers are not functioning at full capacity and may struggle to break down excess bilirubin.

During pregnancy, the mother's placenta removes bilirubin from the baby's blood. After birth, the baby's liver takes over this role. However, it may take some time for the baby's liver to be able to do this efficiently. As a result, bilirubin can build up in the baby's blood, tissues, and fluids, causing jaundice.

Bilirubin is a natural by-product of the breakdown of old red blood cells. While the liver typically breaks down and removes bilirubin from the body, newborn babies' livers may not be mature enough to process it effectively. This is why jaundice is a common condition in newborns, affecting about 60% of full-term newborns and 80% of premature babies.

In addition to the yellowing of the skin and eyes, symptoms of jaundice in newborns may include increased sleepiness, fussiness, and difficulty feeding. It is important to monitor bilirubin levels in newborns with jaundice to ensure that they do not reach harmful levels. While mild jaundice usually resolves on its own within a few weeks, high levels of bilirubin can lead to serious complications such as hearing loss, seizures, and brain damage.

Mild jaundice usually clears up without treatment

Mild jaundice is a common condition in newborn babies, affecting around 60% of newborns. It is caused by a build-up of bilirubin in the blood, which is produced during the breakdown of red blood cells. A newborn's liver may not be mature enough to process and remove bilirubin quickly enough, leading to a build-up that causes the skin and eyes to turn yellow.

However, it is important to closely monitor bilirubin levels in newborns with jaundice. Very high levels of bilirubin can lead to hearing loss, seizures, and brain damage. If you notice any concerning symptoms, such as increased sleepiness or deepening of the yellow colouring, contact your baby's healthcare provider.

To help prevent jaundice in newborns, it is recommended to initiate breastfeeding as soon as possible, preferably within the first hour after birth. Early and frequent breastfeeding helps eliminate bilirubin from the baby's body.

Severe jaundice may require phototherapy or an exchange transfusion

It is common for newborn babies to have yellowish eyes and skin due to a condition called jaundice. Jaundice is caused by a build-up of bilirubin, an orange/red pigment in the blood, which is produced by the normal breakdown of red blood cells. Small to medium increases in bilirubin are normal in newborns and will not harm your baby. However, very high levels of bilirubin can be dangerous and lead to hearing loss, seizures, and brain damage.

If a baby has severe jaundice, they may require treatment such as phototherapy or an exchange transfusion. Phototherapy is a common and highly effective treatment that uses light to eliminate bilirubin from the blood. During phototherapy, the baby's skin and blood absorb light waves, which change bilirubin into products that can pass through their system.

In very severe cases of jaundice, an exchange transfusion may be necessary. This procedure involves the removal of the infant's blood and its simultaneous replacement with compatible donor blood. Exchange transfusion provides a rapid reduction in circulating bilirubin and can be an appropriate treatment for severe hyperbilirubinemia in the neonatal period. The risk of treatment includes potential complications such as cardiac and respiratory disorders, shock due to bleeding or inadequate blood replacement, infection, and blood clots.

To determine the appropriate treatment for jaundice, it is important to monitor bilirubin levels through periodic blood samples. Feeding the baby frequently (at least 8 times a day) can also help to reduce bilirubin levels as it passes through the baby's body.

Jaundice is more common in premature babies

Jaundice is a condition that causes a newborn baby's skin and eyes to turn yellow. This occurs when there is a build-up of bilirubin in the baby's blood, which is produced during the breakdown of red blood cells. While jaundice is common in newborn babies, it is more prevalent in premature babies, with around 80% of preterm babies developing jaundice. This is because a premature baby's liver is not fully developed and is less able to remove bilirubin from the blood.

Jaundice typically appears within the first few days after birth and usually resolves within 1 to 2 weeks. However, in premature babies, jaundice may last longer and tend to be more severe than in full-term babies.

It is important to monitor jaundice in premature babies as high levels of bilirubin can lead to serious complications such as acute bilirubin encephalopathy and kernicterus, which can cause permanent brain damage. Treatment for jaundice in premature babies may include phototherapy, exchange transfusion, or intravenous immunoglobulin, depending on the severity of the condition.

To summarise, jaundice is more common in premature babies due to their underdeveloped livers, and it can have more severe consequences, so it is crucial to monitor and treat jaundice in this vulnerable population.

Frequently asked questions